Cargando…

LncRNA DIO3OS regulated by TGF-β1 and resveratrol enhances epithelial mesenchymal transition of benign prostatic hyperplasia epithelial cells and proliferation of prostate stromal cells

BACKGROUND: The etiopathogenesis of benign prostatic hyperplasia (BPH) is extremely complicated which involving epithelial-mesenchymal transition (EMT) of epithelial cells and growth of stromal cells. Long non-coding RNAs (lncRNAs) belong to a group of noncoding RNAs which has been widely studied in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yanbo, Xu, Hui, Liu, Chong, Gu, Meng, Zhan, Ming, Chen, Qi, Wang, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947439/ https://www.ncbi.nlm.nih.gov/pubmed/33718067 http://dx.doi.org/10.21037/tau-20-1169

Ejemplares similares

Androgen Receptor Expression in Epithelial and Stromal Cells of Prostatic Carcinoma and Benign Prostatic Hyperplasia
por: Filipovski, Vanja, et al.
Publicado: (2017)

Stimulation of prostate cells by the senescence phenotype of epithelial and stromal cells: Implication for benign prostate hyperplasia
por: Jiang, Shoulei, et al.
Publicado: (2019)

Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation
por: Zhang, Bo, et al.
Publicado: (2021)

Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
por: Sirab, Nanor, et al.
Publicado: (2013)

Possible clinical implications of prostate capsule thickness and glandular epithelial cell density in benign prostate hyperplasia
por: Holder, Katherine G., et al.
Publicado: (2021)

Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells
por: Jung, Yunu, et al.
Publicado: (2017)

Altered expression of lncRNA NCK1-AS1 distinguished patients with prostate cancer from those with benign prostatic hyperplasia
por: Guan, Zhihui, et al.
Publicado: (2019)

The Symptoms of Benign Prostatic Hyperplasia Patients with Stromal-Dominated Hyperplasia Nodules May Be Associated with Prostate Fibrosis
por: Cao, Ying, et al.
Publicado: (2023)

Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia
por: Hata, Junya, et al.
Publicado: (2023)

Resveratrol Suppresses Prostate Cancer Epithelial Cell Scatter/Invasion by Targeting Inhibition of Hepatocyte Growth Factor (HGF) Secretion by Prostate Stromal Cells and Upregulation of E-cadherin by Prostate Cancer Epithelial Cells
por: Hsieh, Tze-chen, et al.
Publicado: (2020)

Regulation of Prostate Development and Benign Prostatic Hyperplasia by Autocrine Cholinergic Signaling via Maintaining the Epithelial Progenitor Cells in Proliferating Status
por: Wang, Naitao, et al.
Publicado: (2016)

Benign Prostatic Hyperplasia
Publicado: (2015)

Cyclopamine functions as a suppressor of benign prostatic hyperplasia by inhibiting epithelial and stromal cell proliferation via suppression of the Hedgehog signaling pathway
por: Yuan, Yi-Feng, et al.
Publicado: (2020)

Correction: Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells
por: Jung, Yunu, et al.
Publicado: (2019)

Resveratrol induces apoptosis of benign prostatic hyperplasia epithelial cell line (BPH-1) through p38 MAPK-FOXO3a pathway
por: Li, Chao, et al.
Publicado: (2019)

Estrogen regulates the proliferation and inflammatory expression of primary stromal cell in benign prostatic hyperplasia
por: Chen, Bo, et al.
Publicado: (2020)

DNMT1 Regulates IL-6- and TGF-β1-Induced Epithelial Mesenchymal Transition in Prostate Epithelial Cells
por: Xu, Hui, et al.
Publicado: (2017)

Imprinted lncRNA Dio3os preprograms intergenerational brown fat development and obesity resistance
por: Chen, Yan-Ting, et al.
Publicado: (2021)

Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia
por: Xu, Deqiang, et al.
Publicado: (2019)

Resveratrol Attenuates the Proliferation of Prostatic Stromal Cells in Benign Prostatic Hyperplasia by Regulating Cell Cycle Progression, Apoptosis, Signaling Pathways, BPH Markers, and NF-κB Activity
por: Jang, Jowon, et al.
Publicado: (2021)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Lack of adiponectin and adiponectin receptor 1 contributes to benign prostatic hyperplasia
por: Fu, Shi, et al.
Publicado: (2017)

The P.R.OS.T.A.T.E Nomogram for the Preoperative Prediction of Clinical Efficacy of Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia Patients
por: Tian, Ye, et al.
Publicado: (2022)

Leptin Mediates Prostate Stromal Cell Proliferation, Smooth Muscle Contraction, and Mitochondrial Function in Benign Prostate Hyperplasia
por: Wang, Xiaolong, et al.
Publicado: (2023)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Metformin inhibits the proliferation of benign prostatic epithelial cells
por: Wang, Zongwei, et al.
Publicado: (2017)

Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis
por: Kim, Sang-Su, et al.
Publicado: (2016)

Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer
por: Zenzmaier, Christoph, et al.
Publicado: (2013)

Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity
por: Fu, Shi, et al.
Publicado: (2017)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Prostatic Stromal Hyperplasia with Atypia
por: Hutchinson, Ryan C., et al.
Publicado: (2013)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

AB012. E-cadherin is down-regulated in benign prostate hyperplasia and required for tight junction formation and permeability barrier in prostatic epithelial cell monolayer
por: Li, Feng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i97irs4fhqtbt8bgv408tps5kf